RESEARCH PEPTIDE PROFILE
Unapproved research compound

Melanotan II

A synthetic melanocortin analogue widely discussed for tanning, but without an approved medical tanning indication and with significant evidence and product-quality concerns.

AEVLI RESEARCHMelanotan IIEDUCATIONAL PROFILE
Research context

This page summarizes published evidence and regulatory context. It does not provide sourcing, dosing, prescribing, reconstitution or administration instructions.

What is Melanotan II?

Melanotan II is a synthetic melanocortin analogue associated with pigmentation and other melanocortin effects. Online popularity is not equivalent to regulatory approval or a well-characterized consumer safety profile.

Proposed mechanism

It acts at melanocortin receptors, pathways involved in pigmentation and several central physiological functions. Receptor activity also helps explain why effects may extend beyond skin pigmentation.

What has been published?

There is historical experimental literature, but it has not produced an FDA-approved Melanotan II medicine for tanning. Case reports and regulator concerns are particularly relevant to real-world use.

Current human evidence

Human exposure has occurred, but there is no mature evidence base supporting unsupervised cosmetic use as safe and effective.

Regulatory status

Melanotan II is not an FDA-approved tanning medicine. FDA lists Melanotan II among bulk substances that may present significant safety risks in compounding, including immunogenicity and impurity concerns.

Possible areas of research interest

  • Melanocortin receptors
  • Pigmentation biology
  • Appetite and central melanocortin signalling
  • Peptide safety and product quality

Important limitations

  • No approved cosmetic-tanning indication
  • Unregulated product identity and purity are uncertain
  • Human safety is not adequately characterized for unsupervised use
  • Online popularity can obscure regulatory warnings

References

AEVLI prioritizes primary publications and regulator materials over anecdotal claims.